Videos

This series features 5 KOLs.

Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, an expert on RSV

Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, provides an overview of respiratory syncytial virus (RSV), highlighting disease transmission, incidence, symptoms, and factors that indicate higher risk of hospitalization.